Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year

CAPRICOR THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year

CAPRICOR THERAPEUTICS, INC. (CAPR) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $1.08 thousand as of 2021-03-31, per its 10-Q filed 2021-05-14.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2021-05-14

  • 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.08K.
  • 2020-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.08K.
  • 2016-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $12.19K.
  • 2016-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $24.38K.
Period endFinite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
2021-03-31$1.08K
10-Q · filed 2021-05-14
2020-09-30$1.08K
10-Q · filed 2020-11-13
2016-09-30$12.19K
10-Q · filed 2016-11-14
2016-06-30$24.38K
10-Q · filed 2016-08-15
2016-03-31$36.56K
10-Q · filed 2016-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63